Advanced or residual ovarian cancer.
Adjuvant in node-positive breast cancer.
Locally advanced metastatic breast cancer.
Advanced non-small cell lung carcinoma.
AIDS-related Kaposi's sarcoma for which prior liposomal anthracycline therapy has failed.
PACLITAXEL
Injectable solution for intravenous use
Box with 1 ampoule vial of 25 mL
Each 25 mL vial contains: Paclitaxel 150 mg
F020217052018
